PE20121538A1 - Combinaciones terapeuticas de teobromina y una antihistamina - Google Patents

Combinaciones terapeuticas de teobromina y una antihistamina

Info

Publication number
PE20121538A1
PE20121538A1 PE2012000814A PE2012000814A PE20121538A1 PE 20121538 A1 PE20121538 A1 PE 20121538A1 PE 2012000814 A PE2012000814 A PE 2012000814A PE 2012000814 A PE2012000814 A PE 2012000814A PE 20121538 A1 PE20121538 A1 PE 20121538A1
Authority
PE
Peru
Prior art keywords
antihistamine
theobromine
therapeutic combinations
therapeutic
combinations
Prior art date
Application number
PE2012000814A
Other languages
English (en)
Spanish (es)
Inventor
John Brew
Robin Mark Bannister
Original Assignee
Biocopea Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Biocopea Ltd filed Critical Biocopea Ltd
Publication of PE20121538A1 publication Critical patent/PE20121538A1/es

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
    • A61K31/4402—Non condensed pyridines; Hydrogenated derivatives thereof only substituted in position 2, e.g. pheniramine, bisacodyl
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
    • A61K31/505—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim
    • A61K31/519—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim ortho- or peri-condensed with heterocyclic rings
    • A61K31/52—Purines, e.g. adenine
    • A61K31/522—Purines, e.g. adenine having oxo groups directly attached to the heterocyclic ring, e.g. hypoxanthine, guanine, acyclovir
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
    • A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A61P11/04—Drugs for disorders of the respiratory system for throat disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A61P11/14—Antitussive agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Landscapes

  • Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Chemical & Material Sciences (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Engineering & Computer Science (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pulmonology (AREA)
  • Epidemiology (AREA)
  • Otolaryngology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicinal Preparation (AREA)
PE2012000814A 2009-12-14 2010-12-14 Combinaciones terapeuticas de teobromina y una antihistamina PE20121538A1 (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GBGB0921803.3A GB0921803D0 (en) 2009-12-14 2009-12-14 Drug composition and its use in therapy

Publications (1)

Publication Number Publication Date
PE20121538A1 true PE20121538A1 (es) 2012-12-21

Family

ID=41667043

Family Applications (1)

Application Number Title Priority Date Filing Date
PE2012000814A PE20121538A1 (es) 2009-12-14 2010-12-14 Combinaciones terapeuticas de teobromina y una antihistamina

Country Status (17)

Country Link
EP (1) EP2512472A1 (pt)
JP (2) JP2013513652A (pt)
CN (1) CN102802625A (pt)
AU (1) AU2010332495C1 (pt)
BR (1) BR112012014159A8 (pt)
CA (1) CA2784215A1 (pt)
CO (1) CO6541638A2 (pt)
GB (1) GB0921803D0 (pt)
IL (1) IL220384A0 (pt)
MX (1) MX2012006624A (pt)
NZ (1) NZ600267A (pt)
PE (1) PE20121538A1 (pt)
RU (1) RU2012129675A (pt)
SG (2) SG181603A1 (pt)
UA (1) UA105827C2 (pt)
WO (1) WO2011073647A1 (pt)
ZA (1) ZA201204294B (pt)

Families Citing this family (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US9314465B2 (en) 2009-06-16 2016-04-19 Infirst Healthcare Limited Drug combinations and uses in treating a coughing condition
GB201111485D0 (en) * 2011-07-05 2011-08-17 Biocopea Ltd Drug composition and its use in therapy
US9308211B2 (en) 2009-06-16 2016-04-12 Infirst Healthcare Limited Drug combinations and uses in treating a coughing condition
US10016437B2 (en) 2009-06-16 2018-07-10 Infirst Healthcare Limited Drug combinations and uses in treating a coughing condition
GB0910375D0 (en) 2009-06-16 2009-07-29 Biocopea Ltd Drug composition and its use in therapy
CN103263533B (zh) * 2013-05-31 2014-11-05 杨宏伟 一种治疗咳嗽的可可碱组合物及其用途及其制剂
CN104188998A (zh) * 2014-09-18 2014-12-10 中山大学 一种柚皮苷与盐酸非索非那丁药物组合物及其制剂
CN104224819B (zh) * 2014-09-18 2016-08-17 中山大学 一种柚皮苷与盐酸左西替利嗪药物组合物及其制剂

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ATE59550T1 (de) * 1986-04-17 1991-01-15 Alza Corp Chlorpheniramine therapie.
HUP9700654A2 (hu) 1997-03-26 1999-09-28 Dezső Korbonits Teobromin tartalmú köhögéscsillapító készítmények
JPH10316568A (ja) * 1997-05-13 1998-12-02 Taisho Pharmaceut Co Ltd 医薬組成物
JP2003012514A (ja) * 2001-07-02 2003-01-15 Taisho Pharmaceut Co Ltd 医薬組成物
JP2003128549A (ja) * 2001-08-15 2003-05-08 Rohto Pharmaceut Co Ltd 粘膜適用組成物
US20080003280A1 (en) * 2006-06-26 2008-01-03 Levine Brian M Combination cough treatment compounds and method of treating common coughs
TW200902025A (en) * 2007-04-11 2009-01-16 Alcon Res Ltd Use of an inhibitor of TNF α plus an antihistamine to treat allergic rhinitis and allergic conjunctivitis

Also Published As

Publication number Publication date
AU2010332495C1 (en) 2016-02-11
SG10201408374WA (en) 2015-01-29
AU2010332495A1 (en) 2012-06-21
WO2011073647A1 (en) 2011-06-23
JP2013513652A (ja) 2013-04-22
GB0921803D0 (en) 2010-01-27
AU2010332495B2 (en) 2015-01-22
SG181603A1 (en) 2012-07-30
CN102802625A (zh) 2012-11-28
EP2512472A1 (en) 2012-10-24
CO6541638A2 (es) 2012-10-16
MX2012006624A (es) 2012-10-05
CA2784215A1 (en) 2011-06-23
IL220384A0 (en) 2012-08-30
ZA201204294B (en) 2013-02-27
BR112012014159A8 (pt) 2017-12-26
BR112012014159A2 (pt) 2017-08-29
JP2016040280A (ja) 2016-03-24
UA105827C2 (uk) 2014-06-25
NZ600267A (en) 2013-07-26
RU2012129675A (ru) 2014-01-27
JP6078605B2 (ja) 2017-02-08

Similar Documents

Publication Publication Date Title
PE20121538A1 (es) Combinaciones terapeuticas de teobromina y una antihistamina
CR20110609A (es) Composicion antimicrobiana y metodos relacionados de uso
SV2011004019A (es) 2-acetamido-5-aril-1,2,4-triazolonas sustituidas y su uso
CR20110596A (es) Composiciones sublinguales de dexmedetomidina y métodos de uso de ellas
AR075442A1 (es) Derivados de aminotetralina, composiciones farmaceuticas que las contienen y sus usos en terapia
PE20121524A1 (es) Combinaciones de compuestos que comprenden inhibidores de la integrasa de vih y otros agentes terapeuticos
CR20120207A (es) Métodos de administración de una terapia con pirfenidona
NI200800175A (es) Uso de derivados de sulfamidas heterocíclicas benzo-fusionadas para el tratamiento de abuso y adicción de sustancias.
EA201100358A1 (ru) Дабигатран для чрескожной хирургической катетеризации сердца
BRPI0822885A2 (pt) Implemento para cuidado oral, método para administrar um agente ativo, e, kit para cuidado oral
BR112012015428A2 (pt) composições de cuidado oral para uso com um dispositivo de luz oral
MX2012007933A (es) Composiciones de dexmedetomidina transdermicas topicas y metodos para su uso.
BR112012013487A2 (pt) Composições de amantadina e métodos de uso
PE20150709A1 (es) Benzamidas
CO7131352A2 (es) Composiciones farmacéuticas tópicas
DOP2011000382A (es) Sulfonamidas heterociclicas, usos y composiciones farmaceuticas de las mismas
AR114032A2 (es) 5-(3,4-dicloro-fenil)-n-(2-hidroxi-ciclohexil)-6-(2,2,2-trifluor-etoxi)-nicotinamida y sales de la misma
AR084652A1 (es) Glicoles como agentes inactivadores de patogenos
BR112012029946A2 (pt) encapsulação de ingredientes em matriz de lactose para formar encapsulados ativos
MY175764A (en) Extended-release formulation for reducing the frequency of urination and method of use thereof
PE20140409A1 (es) Derivados de 4-(5-ciano-pirazol-1-il)-piperidina como moduladores de gpr 119
CL2009001841A1 (es) Uso de una composición de liberación sostenida de 4-aminopiridina para preparar un medicamento útil para tratar esclerosis multiple en un sujeto.
UY31000A1 (es) Oxoisoxazoles como inhibidores de lipasas y fosfolipasas
PE20121537A1 (es) Combinacion de teobromina con un descongestivo
AR078323A1 (es) Tratamiento con fampridina de liberacion sostenida en pacientes con esclerosis multiple

Legal Events

Date Code Title Description
FC Refusal